301093 Jiangsu Hualan New Pharmaceutical Material
- 22.60
- -0.21-0.92%
Jiangsu Hualan New Pharmaceutical Material News
Express News | Hualan Co., Ltd.: Net profit returned to mother in the first quarter was 10.6794 million yuan, a year-on-year decrease of 67.88%
Hualan Co., Ltd. (301093.SZ) announced its 2023 annual results, with net profit of 118 million yuan, an increase of 25.79%
Hualan Co., Ltd. (301093.SZ) released its 2023 annual report. The company's revenue was 623 million yuan...
Hualan Co., Ltd. (301093.SZ): Repurchase completed, 4.72% of shares have been repurchased
Gelonghui March 13 | Hualan Co., Ltd. (301093.SZ) announced that as of March 11, 2024, the repurchase plan has been completed. The company's actual repurchase period was from June 5, 2023 to March 11, 2024. The total amount of shares repurchased by the company using overraised capital through centralized bidding was 6,412,625 shares, accounting for 4.72% of the company's total share capital. The highest purchase price was 35.108 yuan/share, and the lowest price was 26.390 yuan/share. The total amount paid was RMB 199.6 million (excluding transaction)
Hualan Co., Ltd. (301093.SZ) has repurchased 4.71% of its shares at a total cost of 199 million yuan
Hualan Co., Ltd. (301093.SZ) announced that the company has accumulated through centralized bidding as of February 29, 2024...
Hualan Co., Ltd. (301093.SZ): A total cost of 199 million yuan to buy back 4.71% of the shares
Gelonghui, Feb. 1 | Hualan Co., Ltd. (301093.SZ) announced that as of January 31, 2024, the total number of shares repurchased by the company using overraised capital through centralized bidding was 6,398,925 shares, accounting for 4.71% of the company's total share capital. The highest purchase price was 35.108 yuan/share, and the lowest price was 27.384 yuan/share. The total amount paid was RMB 199 million (excluding transaction fees).
Hualan Co., Ltd. (301093.SZ): The cumulative cost was about 188 million yuan to buy back 4.42% of the shares
Gelonghui, January 25 | Hualan Co., Ltd. (301093.SZ) announced that as of January 25, 2024, the total number of shares repurchased by the company using overraised capital through centralized bidding was 5,998,800 shares, accounting for 4.42% of the company's total share capital. The highest purchase price was 35.108 yuan/share, and the lowest price was 28.028 yuan/share. The total amount paid was approximately RMB 188 million (excluding transaction fees).
Hualan Co., Ltd. (301093.SZ) will receive 56.67 million yuan in special government funding
Hualan Co., Ltd. (301093.SZ) announced that recently, the company successfully declared a project and approved 56 financial resources for the project...
Hualan Co., Ltd. (301093.SZ): 3.20% of shares have been cumulatively repurchased
Gelonghui, January 18, 丨 Hualan Co., Ltd. (301093.SZ) announced that as of January 18, 2024, the total number of shares repurchased by the company using overraised capital through centralized bidding was 4,346,100 shares, accounting for 3.20% of the company's total share capital. The highest purchase price was 35.108 yuan/share, and the lowest price was 29.930 yuan/share. The total amount paid was approximately RMB 139 million (excluding transaction fees).
Hualan Co., Ltd. (301093.SZ): It has spent a total of 94.1084 million yuan to buy back 2.16% of the shares
Gelonghui, January 17 | Hualan Co., Ltd. (301093.SZ) announced that as of January 17, 2024, the total number of shares repurchased by the company using overraised capital through centralized bidding was 2,937,800 shares, accounting for 2.16% of the company's total share capital. The highest purchase price was 35.108 yuan/share, and the lowest price was 29.930 yuan/share. The total amount paid was RMB 94.1084 million (excluding transaction fees).
Hualan Co., Ltd. (301093.SZ): 1.39% of shares have been repurchased cumulatively
Gelonghui, January 16 | Hualan Co., Ltd. (301093.SZ) announced that as of January 16, 2024, the total number of shares repurchased by the company using overraised capital through centralized bidding was 1.885,400 shares, accounting for 1.39% of the company's total share capital. The highest purchase price was 35.108 yuan/share, and the lowest price was 29.930 yuan/share. The total amount paid was RMB 605.627 million (excluding transaction fees).
Hualan Co., Ltd. (301093.SZ): A total cost of 26.994 million yuan to buy back 8054 million shares
Gelonghui, January 2 | Hualan Co., Ltd. (301093.SZ) announced that as of December 31, 2023, the total number of shares repurchased by the company using overfunded capital through centralized bidding was 8054 million shares, accounting for 0.59% of the company's total share capital. The highest purchase price was 35.108 yuan/share, and the lowest price was 31.500 yuan/share. The total amount paid was RMB 26.994 million (excluding transaction fees).
Hualan Co., Ltd. (301093.SZ): Repurchased 8054 million shares at a total cost of RMB 26.999.37 million
Gelonghui Co., Ltd. (301093.SZ) announced on November 30, 2023, that as of November 30, 2023, the company used overraised funds to repurchase the company's shares through centralized bidding through special securities repurchase accounts, accounting for 0.59% of the company's total share capital. The maximum purchase price was 35.108 yuan/share, and the minimum price was 31.500 yuan/share. The total payment amount was RMB 26.999.37 million (excluding transaction fees).
Hualan Co., Ltd. (301093.SZ): The subsidiary received a government subsidy of 30 million yuan
On November 22|Hualan Co., Ltd. (301093.SZ) announced that Hualan Co., Ltd., a wholly-owned subsidiary of Chongqing Fuling Sanhai Lanling Co., Ltd., has received a special construction support fund of RMB 30 million from the Finance and Finance Department of the Chongqing Fuling High-tech Industrial Development Zone Management Committee for the project's infrastructure, environmental protection and energy saving. The Sanhai Lanling Mausoleum has already received this amount of government aid.
Hualan Co., Ltd. (301093.SZ): Repurchased 0.59% of shares at a cumulative cost of RMB 26.999 million
Glonghui Co., Ltd. (301093.SZ) announced on October 31, 2023, that as of October 31, 2023, the company used overraised funds to repurchase the company's shares through centralized bidding through special securities repurchase accounts, accounting for 0.59% of the company's total share capital. The maximum purchase price was 35.108 yuan/share, the lowest price was 31.500 yuan/share, and the total payment amount was RMB 26,999,371.530.
Hualan Co., Ltd. (301093): Steady performance and expectations for new products
3Q23 Revenue increased 9% year over year. The company announced that revenue, net profit attributable to parent, and net profit not attributable to parent were 4.5, 0.9 million yuan, and 50 million yuan respectively from the same period, +11%, +17%, and -8% year-on-year. The growth rate after deducting non-net profit was lower than
Hualan Co., Ltd. (301093.SZ) released results for the first three quarters, with net profit of 89.3062 million yuan, an increase of 16.50% over the previous year
Hualan Co., Ltd. (301093.SZ) released its report for the first three quarters of 2023, with revenue of 454 million yuan, the same...
Hualan Co., Ltd. (301093): Stock payments affect performance and the release of new production capacity can be expected
Event: The company released its three-quarter report for 2023. In the first three quarters, it achieved operating income of 454 million yuan, an increase of 11.42% over the previous year, net profit of 89.31 million yuan, an increase of 16.50% over the previous year, minus 4852 million yuan in non-net profit
Hong Kong Stock Concept Tracking | The concept of diet pills continues to be popular. Institutions: It is recommended to select stocks from four perspectives
Wegovy, the “magic medicine for weight loss,” is in high demand, and Novo Nordisk (NVO.US) has once again raised its annual performance guidelines.
Hualan Co., Ltd. (301093): Grasping the new growth curve of domestically produced pharmaceutical rubber stoppers to set sail for pharmaceutical packaging materials
A leading pharmaceutical rubber stopper company. It has been deeply involved for many years to help replace domestic products. It was covered for the first time. It was given a “buy” rating. Hualan Co., Ltd. has been deeply involved in the pharmaceutical rubber stopper field for 31 years. It has firmly occupied a leading position in research and development, stable quality, and brand building. In recent years, it has achieved rapid response capabilities
Hualan Co., Ltd. (301093): Stable business with more than 2,000 projects in operation
1H23 revenue and attribution increased 13% year on year, and 7%. The company announced that 1H23 achieved revenue, net return profit, and net profit not attributable to parent of $3.0, 0.6 million yuan, and 0.4 billion yuan, respectively. +13%, +7%, and -7% year-on-year increase in profit
Analysis
Price Target
No Data
